CLIVE BADMAN¹, JAGJIT SINGH SRAI²
1. Director of Research in the Department of Engineering, University of Cambridge, and Head of Centre for International Manufacturing, Institute for Manufacturing, United Kingdom
2. Professor Clive Badman OBE FRSE
Executive Director, Business Engagement Group, University of Strathclyde

In Collaboration as the Best Medicine (1) published in Chemistry Today in 2019 we noted that after the highly successful ReMediES programme, collaborative work would continue through the newly approved Medicines Manufacturing Innovation Centre (MMIC) (2) located in Glasgow.

MMIC is a unique partnership providing companies of all sizes with a technologically advanced GMP-capable environment that they can use to develop a more agile, responsive, and sustainable medicines supply chain for the pharmaceutical industry through enhanced manufacturing processes.

To deliver on this promise the centre has set a series of Grand Challenges (GC) that each focus on a specific problem raised by industry. The new technologies being developed will position the UK at the forefront of pharmaceutical manufacture. The radical model of collaboration between academia and industry, builds upon that developed in ReMediES and provides the diverse knowledge, technology and skills required to make the new centre a success. It is the first time two of the UK’s leading pharmaceutical companies GSK and AstraZeneca have combined their manufacturing-technological ...